Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Non-Current Deferred Tax Liability (2012 - 2026)

Omnicell's (OMCL) quarterly Non-Current Deferred Tax Liability came in at $640000.0 in Q2 2026, down 51.26% year-over-year from $1.3 million in Q2 2025, and little changed quarter-over-quarter from $638000.0 in Q1 2026.

Analysis

Omnicell (OMCL) Non-Current Deferred Tax Liability (2012 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Non-Current Deferred Tax Liability for 15 consecutive years, with $640000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 51.26% year-over-year to $640000.0 in Q2 2026; TTM through Jun 2026 was $640000.0, a 51.26% decrease from a year earlier, with the FY2025 full-year figure at $683000.0, down 99.18% from the prior year.
  • Non-Current Deferred Tax Liability was $640000.0 for Q2 2026 at Omnicell, roughly flat from $638000.0 in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $98.9 million in Q4 2022 and troughed at $638000.0 in Q1 2026.
  • A 5-year average of $19.5 million and a median of $1.5 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
  • The widest YoY moves for Non-Current Deferred Tax Liability: up 0.98% in 2025, down 99.18% in 2025.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $98.9 million in 2022, then decreased by 12.82% to $86.3 million in 2023, then decreased by 2.93% to $83.7 million in 2024, then slumped by 99.18% to $683000.0 in 2025, then declined by 6.3% to $640000.0 in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $640000.0 (Q2 2026), $638000.0 (Q1 2026), and $683000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 640,000.00
Mar 31, 2026 638,000.00
Dec 31, 2025 683,000.00
Sep 30, 2025 1.26 Mn
Jun 30, 2025 1.31 Mn
Mar 31, 2025 1.17 Mn
Dec 31, 2024 83.73 Mn
Sep 30, 2024 1.41 Mn
Jun 30, 2024 1.33 Mn
Mar 31, 2024 1.49 Mn
Dec 31, 2023 86.26 Mn
Sep 30, 2023 1.57 Mn
Jun 30, 2023 1.51 Mn
Mar 31, 2023 1.56 Mn
Dec 31, 2022 98.94 Mn
Sep 30, 2022 16.14 Mn
Jun 30, 2022 23.91 Mn
Mar 31, 2022 28.17 Mn
Dec 31, 2021 110.28 Mn
Sep 30, 2021 53.31 Mn